Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for July, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- FED Front & Center Again
- Roundtable Top Picks of the Week
- RTI: Sector Strength Charts - Where's the Opportunity Now?
- Surging Financial ETFs Beating the Market
- Utility Industry Stock Outlook - June 2013
- 3 Japanese Stocks to Buy Now
- Your Next Stock Should Be Making New Highs
- Anatomy of Success: Stoneridge (SRI)
- RTI: What Will the Fed Do Wednesday?
- AWS 6/19: Will Bernanke Clarify Matters Today?
- PFP 6/19: Investors Bold in Wake of the Fed
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 06/19/2013
| Company Name | Symbol | %Change |
|---|---|---|
| LUMOS NETWOR | LMOS | 5.82% |
| SUPPORTCOM I | SPRT | 4.19% |
| E HOUSECHINA | EJ | 3.40% |
| INGLES MARKE | IMKTA | 3.18% |
| SUMITOMO MIT | SMFG | 3.15% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Medical Action Industries manufactures disposable medical products including Operating Room Disposable supplies, Containment Systems for Medical Waste, Minor Procedure Kits and Trays, Bedside Products and supplies for medical laboratories.
Its customers are primarily acute facilities but it has expanded to include physician, dental and veterinary offices, out-patient surgery centers and long-term care facilities.
Medical Action Industries Surprised for the 4th Quarter in a Row
On June 2, Medical Action Industries reported fiscal fourth quarter 2010 results and beat the Zacks Consensus by 25%. Earnings per share were 30 cents compared with the consensus of 24 cents. It reported just 11 cents in the year ago period.
Sales, however, dipped 2% to $71.2 million from $72.9 million in the year ago quarter. The reason that EPS was up significantly while sales slipped compared to last year was that the company benefited from lower raw material costs and also fixed production issues in the Gallaway, Tennessee manufacturing facility.
It was able to eliminate its backorders and keep the cost of products from China at stable prices which added to the bottom line.
The company also paid down debt during the quarter.
Zacks Consensus Estimates Rise
Medical Action Industries did not provide guidance for fiscal 2011. Given the fourth straight earnings surprise, analysts moved to revise estimates higher.
The fiscal first quarter Zacks Consensus Estimate rose a penny to 23 cents in the last month.
The fiscal 2011 Zacks Consensus Estimate also jumped by 5 cents to 94 cents in the prior 30 days with 2 out of 3 estimates moving higher during that time.
Other Value Credentials
The company already has a forward P/E that would be considered a "value" indicator. It also has a price-to-book ratio of just 1.4, which is also within value parameters and well under the industry average of 2.5.
Medical Action Industries price-to-sales ratio also flashes "value" at just 0.7. The industry average is 2.3.
Additionally, the company has a one year return on equity (ROE) of 12.6%, besting the industry which averages 6.7%.
Medical Action Industries is also a Zacks #1 Rank (strong buy) stock.
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor in charge of the market-beating Zacks Value Trader service.
Get the full Snapshot Report on MDCI - FREE